Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
5.23Current Ratio
VS
Market
Sector
Industry
History
$ 23.95Close
$ 6.43 - $ 27.76 52-Week Range
Ticker Information
Ticker
ZBIOCompany Name
ZENAS BIOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQZENAS BIOPHARMA INC - Current Ratio Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ZBIO - Current Ratio Historical data
| Date | Current Assets | Current Ratio | Current Liabilities |
|---|---|---|---|
| 6/30/2025 | $ 278.6M | 5.23 | $ 53.24M |
| 3/31/2025 | $ 317.81M | 6.47 | $ 49.13M |
| 12/31/2024 | $ 355.92M | 6.21 | $ 57.29M |
| 9/30/2024 | $ 393.78M | 8.95 | $ 44M |
| 6/30/2024 | $ 188.6M | 4.82 | $ 39.11M |
| 12/31/2023 | $ 59.8M | 2.57 | $ 23.26M |
Key Performance Insights, Last 5 Years
- ZENAS BIOPHARMA INC's latest trailing twelve months (TTM) Current Ratio stands at 2.57.
- Over the past 5 years, ZENAS BIOPHARMA INC's average Current Ratio has been 5.71.
- The median Current Ratio for ZENAS BIOPHARMA INC during this period was 5.72
- ZENAS BIOPHARMA INC reached its highest Current Ratio over the past 5 years at 8.95.
- The lowest Current Ratio recorded by ZENAS BIOPHARMA INC in the same timeframe 2.57
ZENAS BIOPHARMA INC's Current Ratio vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Current Ratio Benchmarks
Similar metrics to LiabilitesC:
- Working Capital - [Calculation] The working capital represents the capital used in day-to-day operations. It is the difference between a company’s short-term assets [AssetsC] and current liabilities [LiabilitiesC].
- Cash Ratio - [Calculation] The Cash Ratio is a liquidity indicator that describes a company's ability to meet short-term obligations with cash and cash equivalents. Calculated by dividing cash and cash equivalents [CashnEq] by current liabilities [LiabilitiesC].
- Quick Ratio - [Calculation] The quick ratio is a liquidity indicator that describes the company’s ability to pay short-term obligations without the need to sell its inventory or receive additional financing. Calculated by dividing current assets [AssetsC] minus [Inventory] by current liabilities [LiabilitiesC].
- Current Liabilities - [Balance Sheet] The current (short-term) portion of [Liabilities] includes obligations that are due to be paid to creditors within one year, reported if the company operates a classified balance sheet that segments current and non-current [Liabilities]
- Total Liabilities - [Balance Sheet] Total liabilities are the sum of all possible claims against the company. Common examples are [Debt], [Payables], deferred revenues, issued bonds, warranties, and tax liabilities.
Definition of Current Ratio
[Calculation] The current ratio is a liquidity indicator that describes the company’s ability to pay short-term obligations due within one year. Calculated by dividing current assets [AssetsC] by current liabilities [LiabilitiesC].AssetsC / LiabilitesC
(=) Current Ratio Current Ratio for ZENAS BIOPHARMA INC is calculated as follows: AssetsC [ $ 59.8M ] / LiabilitesC [ $ 23.26M ]
(=) Current Ratio [ 2.57 ] ZBIO - Current Ratio, Last 5 years
2.57
Minimum
Dec 31, 2023
8.95
Maximum
Sep 30, 2024
5.71
Average
5.72
Median
Current Ratio Benchmark AnalysisMarket
The chart above depicts the distribution of Current Ratio for companies in the Total Stock Market. The average Current Ratio of the companies is 2.02 with a standard deviation of 1.44.
The following table provides additional summary stats:
Current Ratio in the Market:
| filtered constituents | 3.2K |
|---|---|
| min | 0 |
| max | 6.79 |
| average | 2.02 |
| median | 1.62 |
| std | 1.44 |